How does a diabetes drug lessen symptoms of depression?

Published On 2024-03-13 18:00 GMT | Update On 2024-03-14 04:03 GMT

Research in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of depression. A new study published in Brain and Behavior reveals the mechanisms that are likely involved.

By conducting a range of tests in mice treated with and without dulaglutide, investigators confirmed the effects of dulaglutide on depressive-like behaviors, and they identified 64 different metabolites and four major pathways in the brain associated with these effects.

Markers of depression and the antidepressant effects of dulaglutide were linked to lipid metabolism, amino acid metabolism, energy metabolism, and tryptophan metabolism.

“These primary data provide a new perspective for understanding the antidepressant-like effects of dulaglutide and may facilitate the use of dulaglutide as a potential therapeutic strategy for depression,” the authors wrote.

Reference:

Man Jin, Shipan Zhang, Boya Huang, Litao Li, Hao Liang, Aihua Ni, Lina Han, Peng Liang, Jing Liu, Haishui Shi, Peiyuan Lv, Dulaglutide treatment reverses depression-like behavior and hippocampal metabolomic homeostasis in mice exposed to chronic mild stress, Brain and Behavior, https://doi.org/10.1002/brb3.3448.

Article Source : Brain and Behavior

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

How does a diabetes drug lessen symptoms of depression?

Similar News

Mindfulness Training Cuts Stress and Rumination While Boosting Resilience in Major Depression: German Trial

Antidepressant Use Linked to Lower Risk of Age-Related Macular Degeneration: Study Shows

GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA

Long-Standing Diabetes Significantly Increases Dementia Risk in Heart Attack Survivors, Study Finds

Some mental conditions raise heart disease risk, mortality rate by nearly 100%, reveals study

Moderate-to-regular daily sleep patterns are associated with enhanced cognitive function: Study

People with schizophrenia have higher risk of COPD, suggests study

Seltorexant effective in initiating sleep in individuals with insomnia: JAMA